DeepMed Research

Peking University Peoples Hospital

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Evaluation of Lung Nodule Detection With Artificial Intelligence Assisted Computed Tomography in North China

Conditions: Solitary Pulmonary Nodule
Multiple Pulmonary Nodules

Interventions: Other: Questionnaire Administration

First Posted Date: 2018-04-04

Last Posted Date: 2018-04-04

Lead Sponsor: Peking University People's Hospital

Target Recruit Count: 5000

Registration Number: NCT03487952

The Combination of Atorvastatin, Acetylcysteine and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia

Phase 1

Conditions: Immune Thrombocytopenia

Interventions: Drug: atorvastatin
Drug: Acetylcysteine
Drug: Danazol

First Posted Date: 2018-03-09

Last Posted Date: 2018-03-09

Lead Sponsor: Peking University People's Hospital

Target Recruit Count: 200

Registration Number: NCT03460808

Locations: 🇨🇳
Peking University Insititute of Hematology, Peking University People's Hospital, Beijing, Beijing, China

Long-term Assessment of Organ Functions Among Survivors of Severe Acute Respiratory Syndrome

Conditions: SARS Virus
Long-Term Survivors

First Posted Date: 2018-02-22

Last Posted Date: 2018-02-26

Lead Sponsor: Peking University People's Hospital

Target Recruit Count: 150

Registration Number: NCT03443102

Locations: 🇨🇳
Peking University People's Hospital, Beijing, Beijing, China

Anlotinib and Irinotecan for Ewing Sarcoma

Phase 1

Conditions: Ewing's Tumor Metastatic

Interventions: Drug: Anlotinib
Drug: Irinotecan

First Posted Date: 2018-01-31

Last Posted Date: 2019-02-15

Lead Sponsor: Peking University People's Hospital

Target Recruit Count: 47

Registration Number: NCT03416517

Locations: 🇨🇳
Peking University First Hospital, Beijing, China
🇨🇳
Peking University People's Hospital, Beijing, China
🇨🇳
Peking University Third Hospital, Beijing, China

and more 2 locations

Denosumab: A Potential Treatment Option for Aneurysmal Bone Cysts

Phase 1

Completed

Conditions: Pathological Fracture
Refractory Tumor
Bone Cyst Aneurysmal
Recurrent Disease

Interventions: Drug: Denosumab (Xgeva)

First Posted Date: 2018-01-30

Last Posted Date: 2018-01-30

Lead Sponsor: Peking University People's Hospital

Target Recruit Count: 6

Registration Number: NCT03415477

RIC Regimen for Low- and Intermediate-risk MDS Receiving Haplo-HSCT

Phase 2

Conditions: Myelodysplastic Syndromes

Interventions: Drug: Cytarabine

First Posted Date: 2018-01-26

Last Posted Date: 2022-04-20

Lead Sponsor: Peking University People's Hospital

Target Recruit Count: 50

Registration Number: NCT03412266

Locations: 🇨🇳
Peking University Institute of Hematology,Beijing, Beijing, Beijing, China

RIC Regimen for Elderly or High Comorbidity Burden Patients Receiving Haplo-HSCT

Phase 2

Recruiting

Conditions: Myelodysplastic Syndromes
Acute Leukemia

Interventions: Drug: Cytarabine

First Posted Date: 2018-01-26

Last Posted Date: 2024-03-26

Lead Sponsor: Peking University People's Hospital

Target Recruit Count: 50

Registration Number: NCT03412409

Locations: 🇨🇳
Peking University, Institute of Hematolgoy, Beijing, China

Internal Fixation or Joint Replacement Therapy for Aged Hip Fracture Patients

Not Applicable

Conditions: Intertrochanteric Fractures

Interventions: Procedure: Intramedullary nail fixation
Procedure: Joint replacement surgery

First Posted Date: 2018-01-23

Last Posted Date: 2018-01-23

Lead Sponsor: Peking University People's Hospital

Target Recruit Count: 100

Registration Number: NCT03407131

Locations: 🇨🇳
Peking University People's Hospital, Peking, China

Prolonged Isolated Thrombocytopenia After Allo-SCT : N-acetyl-L-cysteine (NAC) Versus Supportive Therapy

Phase 2

Terminated

Conditions: Thrombocytopenia
Stem Cell Transplant Complications

Interventions: Drug: N-acetyl-L-cysteine (NAC)
Other: supportive therapy

First Posted Date: 2018-01-05

Last Posted Date: 2020-09-25

Lead Sponsor: Peking University People's Hospital

Target Recruit Count: 15

Registration Number: NCT03391856

Locations: 🇨🇳
Peking University People's Hospital, Beijing, Beijing, China

Activity Trackers for Monitoring During Rehabilitation After Total Knee Arthroplasty

Not Applicable

Conditions: Total Knee Arthroplasty

Interventions: Device: Fitbit One, the activity tracker

First Posted Date: 2017-12-11

Last Posted Date: 2017-12-11

Lead Sponsor: Peking University People's Hospital

Target Recruit Count: 100

Registration Number: NCT03368287

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy